ZA201102615B - Efficient expression of truncated human rnaset2 in e coli - Google Patents

Efficient expression of truncated human rnaset2 in e coli

Info

Publication number
ZA201102615B
ZA201102615B ZA2011/02615A ZA201102615A ZA201102615B ZA 201102615 B ZA201102615 B ZA 201102615B ZA 2011/02615 A ZA2011/02615 A ZA 2011/02615A ZA 201102615 A ZA201102615 A ZA 201102615A ZA 201102615 B ZA201102615 B ZA 201102615B
Authority
ZA
South Africa
Prior art keywords
coli
efficient expression
truncated human
human rnaset2
rnaset2
Prior art date
Application number
ZA2011/02615A
Other languages
English (en)
Inventor
Oded Shoseyov
Betty Schwartz
Levava Roiz
Patricia Smirnoff
Liron Nuttman
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of ZA201102615B publication Critical patent/ZA201102615B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA2011/02615A 2008-10-30 2011-04-08 Efficient expression of truncated human rnaset2 in e coli ZA201102615B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19313408P 2008-10-30 2008-10-30
PCT/IL2009/001012 WO2010049933A1 (en) 2008-10-30 2009-10-29 Efficient expression of truncated human rnaset2 in e. coli

Publications (1)

Publication Number Publication Date
ZA201102615B true ZA201102615B (en) 2012-03-28

Family

ID=41694413

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/02615A ZA201102615B (en) 2008-10-30 2011-04-08 Efficient expression of truncated human rnaset2 in e coli

Country Status (8)

Country Link
US (1) US20110207667A1 (enExample)
EP (1) EP2346993A1 (enExample)
JP (1) JP2012507278A (enExample)
AU (1) AU2009309277A1 (enExample)
CA (1) CA2739705A1 (enExample)
EA (1) EA201100610A1 (enExample)
WO (1) WO2010049933A1 (enExample)
ZA (1) ZA201102615B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150009953A (ko) * 2012-02-29 2015-01-27 에프. 호프만-라 로슈 아게 1→3 해독 프레임 이동의 감소 방법
US11685935B2 (en) * 2013-05-29 2023-06-27 Cellectis Compact scaffold of Cas9 in the type II CRISPR system
US20160340659A1 (en) 2014-01-30 2016-11-24 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
JP7082945B2 (ja) * 2016-03-17 2022-06-09 シーダーズ―シナイ メディカル センター Ｒｎａｓｅｔ２により炎症性腸疾患を診断する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001021830A1 (en) * 1999-09-24 2001-03-29 Ambion, Inc. Nuclease inhibitor cocktail
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
BRPI0516302A (pt) * 2004-09-29 2008-09-02 Yissun Res Dev Company Of The rnase t2 humana recombinante e suas utilizações
US7608413B1 (en) * 2005-03-25 2009-10-27 Celera Corporation Kidney disease targets and uses thereof

Also Published As

Publication number Publication date
AU2009309277A1 (en) 2010-05-06
AU2009309277A8 (en) 2011-05-12
EA201100610A1 (ru) 2011-10-31
EP2346993A1 (en) 2011-07-27
US20110207667A1 (en) 2011-08-25
WO2010049933A1 (en) 2010-05-06
CA2739705A1 (en) 2010-05-06
JP2012507278A (ja) 2012-03-29

Similar Documents

Publication Publication Date Title
IL249941A0 (en) Spiro-oxaindole substances and medical preparations containing them
GB0803018D0 (en) Therapeutic compounds and their use
PL2510072T3 (pl) Terapeutyczne i kosmetyczne kompozycje elektroluminescencyjne
GB0817207D0 (en) therapeutic apsac compounds and their use
PL2278952T3 (pl) Środki do czyszczenia skóry i rąk
GB0804685D0 (en) Therapeutic compounds and their use
IL218212A0 (en) Therapeutic methods and compositions
GB0817208D0 (en) Therapeutic apsap compounds and their use
GB0807609D0 (en) Therapeutic compounds and their use
EP2268281A4 (en) THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
ZA201201287B (en) Therapeutic aryl-amido-aryl compounds and their use
IL214355A0 (en) Antibodies against human tweak and uses thereof
IL215154A0 (en) Photodynamic disinfection compositions and uses thereof
EP2404592A4 (en) HAIR TREATMENT COMPOSITION
IL213207A0 (en) Dihydroetorphines and their preparation
GB201211237D0 (en) CDK5 inhibitors and therapeutic uses thereof
GB0908868D0 (en) Depsipeptide and their therapeutic use
ZA201105125B (en) Hair treatment composition
ZA201102615B (en) Efficient expression of truncated human rnaset2 in e coli
GB0812913D0 (en) Therapeutic compounds and their use
ZA201201116B (en) Hair treatment composition
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
GB0812080D0 (en) Human propeeled boat
GB0802128D0 (en) Therapeutic compounds and their use
IL212588A0 (en) Efficient expression of truncated human rnaset2 in e. coli